thiazolyl blue has been researched along with Kahler Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramani, VC; Sanderson, RD | 1 |
| Cheikina, NN; Chernykh, YB; Kravtsova, TA; Shushanov, SS | 1 |
| Adams, J; Altamirano, C; Berenson, JR; Borad, MJ; Frantzen, M; Friedman, JM; Ma, MH; Manyak, S; Mikail, A; Neeser, J; Parker, K; Roussos, E; Sjak-Shie, N; Vescio, RA; Wu, ZQ; Yang, HH | 1 |
| Anderson, KC; Chauhan, D; Hideshima, T; Kharbanda, S; Li, G; Mitsiades, C; Mitsiades, N; Munshi, N; Podar, K | 1 |
| Gera, J; Hsu, JH; Lichtenstein, A; Shi, Y; Van Ness, B | 1 |
| Cohen, FJ; Gui, D; Ikezoe, T; Koeffler, HP; Kumagai, T; O'Kelly, J; Said, JW; Tong, XJ | 1 |
| Alsina, M; Beam, C; Beaupre, DM; Dalton, W; Gerbino, E; Hamilton, AD; Kerr, WG; Lichtenheld, MG; Mackley, PA; Muro-Cacho, C; Sebti, SM; Zhu, K | 1 |
| Lee, J; Wu, XH; Zhou, HJ | 1 |
| Kulcsár, G | 1 |
9 other study(ies) available for thiazolyl blue and Kahler Disease
| Article | Year |
|---|---|
Chemotherapy stimulates syndecan-1 shedding: a potentially negative effect of treatment that may promote tumor relapse.
Topics: ADAM Proteins; Animals; Antineoplastic Agents; Blotting, Western; Bone Marrow; Caspase Inhibitors; DNA Primers; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Matrix Metalloproteinase Inhibitors; Mice; Multiple Myeloma; Real-Time Polymerase Chain Reaction; Recurrence; Syndecan-1; Tetrazolium Salts; Thiazoles; Tumor Microenvironment | 2014 |
Insulin Effects on Survival of Human Multiple Myeloma Cells.
Topics: Cell Differentiation; Cell Line, Tumor; Cell Survival; DNA Primers; Electrophoresis, Agar Gel; Gene Expression Regulation, Neoplastic; Humans; Immunophenotyping; Insulin; Intercellular Signaling Peptides and Proteins; Multiple Myeloma; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles | 2015 |
The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents.
Topics: Active Transport, Cell Nucleus; Adenoviridae; Antineoplastic Agents; Apoptosis; Blotting, Western; Boronic Acids; Bortezomib; Cell Division; Cell Nucleus; Cell Survival; Cysteine Endopeptidases; Cytosol; Dose-Response Relationship, Drug; Genes, Dominant; Humans; I-kappa B Proteins; Melphalan; Microscopy, Fluorescence; Multienzyme Complexes; Multiple Myeloma; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Proteasome Endopeptidase Complex; Pyrazines; Tetrazolium Salts; Thiazoles; Time Factors; Transfection; Tumor Cells, Cultured; Ubiquitin | 2003 |
JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells.
Topics: Anthracenes; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Carrier Proteins; Cell Line; Coloring Agents; Cytochrome c Group; Cytosol; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme Inhibitors; Genes, Dominant; Green Fluorescent Proteins; Humans; Immunoblotting; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Luminescent Proteins; MAP Kinase Kinase 4; Membrane Potentials; Mitochondria; Mitochondrial Proteins; Mitogen-Activated Protein Kinase Kinases; Models, Biological; Multiple Myeloma; Serine; Tetrazolium Salts; Thiazoles; Time Factors; Transfection; Tumor Cells, Cultured | 2003 |
Cytoreductive effects of farnesyl transferase inhibitors on multiple myeloma tumor cells.
Topics: Alkyl and Aryl Transferases; Apoptosis; Blotting, Western; Cell Cycle; Cell Division; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Farnesyltranstransferase; Flow Cytometry; Genes, ras; Humans; Interleukin-6; Mitogen-Activated Protein Kinases; Multiple Myeloma; Mutation; NF-kappa B; Phosphorylation; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Tetrazolium Salts; Thiazoles; Time Factors; Transfection | 2003 |
RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by
Topics: Agar; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Caspases; CD36 Antigens; Cell Cycle; Cell Differentiation; Cell Division; Cell Line, Tumor; Cell Survival; Genetic Linkage; Humans; Immunologic Deficiency Syndromes; Ligands; Luciferases; Male; Mice; Multiple Myeloma; Oxides; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Tetrazolium Salts; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Transfection; U937 Cells; X Chromosome | 2004 |
Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cells.
Topics: Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Bone Marrow Cells; Caspase 3; Caspases; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Proliferation; Cisplatin; Clinical Trials as Topic; Cytochromes c; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Enzyme Activation; Farnesyltranstransferase; Flow Cytometry; Fluorouracil; G2 Phase; Gemcitabine; Homozygote; Humans; In Situ Nick-End Labeling; Inhibitory Concentration 50; Mice; Mice, SCID; Mitosis; Multiple Myeloma; Paclitaxel; Quinolones; Taxoids; Tetrazolium Salts; Thiazoles | 2005 |
Dihydroartemisinin inhibits angiogenesis induced by multiple myeloma RPMI8226 cells under hypoxic conditions via downregulation of vascular endothelial growth factor expression and suppression of vascular endothelial growth factor secretion.
Topics: Allantoin; Angiogenesis Inhibitors; Animals; Artemisinins; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Chick Embryo; Culture Media, Conditioned; Down-Regulation; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; Humans; Hypoxia; Membranes; Multiple Myeloma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sesquiterpenes; Signal Transduction; Tetrazolium Salts; Thiazoles; Vascular Endothelial Growth Factor A | 2006 |
Synergistic potentiating effect of D(+)-mannose, orotic, and hippuric acid sodium salt on selective toxicity of a mixture of 13 substances of the circulatory system in culture for various tumor cell lines.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cell Line; Colorimetry; Dogs; Drug Resistance, Multiple; Hippurates; Humans; Macaca mulatta; Mannose; Mice; Multiple Myeloma; Neoplasms, Experimental; Orotic Acid; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2000 |